The clinic will be able to accommodate 1,500 patients over a long period and 50 patients with a left ventricular assist ...

FineHeart announced that it completed the $40.7 million first closing of its Series C financing round to support its heart ...

Preliminary results from the FULCRUM-VT trial point to a safer, more effective way to treat ventricular tachycardia—a dangerous heart rhythm disorder that can lead to sudden cardiac arrest.

SynCardia Systems will work with design firm Hydrix on the development of the Emperor, a next-gen, fully implantable Total ...